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Background: In patients with Latent Autoimmune Diabetes in Adults (LADA) a lower body mass index was
reported compared with classical type 2 diabetes (T2D), and was found to be associated with a faster progression
to insulin-dependence. In this study we determined the body composition in a cohort of LADA patients from
Sardinia, Italy, and compared it with age– and gender–matched patients diagnosed as having adult-onset type 1
diabetes (T1D) and non-autoimmune T2D.
Methods: In 210 LADA patients, 210 T2D patients and 30 adult-onset T1D patients of Sardinian origin we assessed
total and segmental body composition (weight-adjusted percent fat mass and lean mass) by using Dual Energy
X-rays Absorptiometry (DXA).
Results: In the whole cohort of LADA patients total fat mass was significantly smaller compared with T2D patients
(p < 0.0001), while no difference was found between LADA and T1D patients. In LADA men fat depletion involved
all body segments, while in LADA women it was observed only in the truncal segment (p < 0.0001), as in the upper and
lower regions fat deposits were larger compared to T2D (p < 0.0001). However, LADA women showed a significantly
elevated truncal fat compared to T1D women (p < 0.004), whereas no difference was detected in the extremities.
Conclusions: Body composition in LADA patients shows substantial difference, in a gender-dependent way, compared
to classic T2D. In women fat deposits tend to accumulate in peripheral regions rather than centrally, whereas in men
the distribution is more homogeneous. In addition, central fat depletion in LADA women appears to be a significant
predictor of faster progression to insulin dependence. Thus, routine assessment of body composition may help the
physician identify LADA patients who require early insulin treatment in order to delay beta-cell exhaustion, as well
those with increased CV risk due to excess truncal adiposity.
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Approximately 5-10% of patients initially diagnosed as
having type 2 diabetes (T2D) mellitus show markers of
autoimmunity against pancreatic beta-cells, such as serum
antibodies to glutamic acid decarboxylase (GADAb), tyro-
sine phosphatase–like protein (I–A2Ab), and islet cell
cytoplasmic antigen (ICA) [1]. This form of diabetes,
referred to as “latent autoimmune diabetes in adults”
(LADA) is often considered a slow-developing form of* Correspondence: gmpes@uniss.it
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unless otherwise stated.type 1 diabetes (T1D) [2,3]. However, many clinical features
of LADA, including onset in adult life, absence of ketoa-
cidosis and slower progression towards insulin dependence,
resemble more closely T2D than T1D. Similarities with
T2D were reported also as regards anthropometric and
metabolic data, although literature data are not entirely
consistent. Family studies such as the Botnia Study in
western Finland [4], which investigated a large cohort of
GADAb-positive diabetic patients, reported that average
body mass index (BMI), waist-to-hip ratio, and frequency
of hypertension were lower – and the level of HDL chol-
esterol higher – compared with antibody-negative T2D. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Trial (ADOPT) study did not find any significant dif-
ference between LADA and T2D in regard to BMI,
blood pressure, glycated hemoglobin and lipid profile
[5]. However, in this study the average waist circumference
and the frequency of metabolic syndrome were signifi-
cantly lower in LADA than in T2D patients, a finding also
reported in a survey of T2D patients from five European
countries, including Italy [6]. Besides these phenotypic
differences between LADA and T2D, a number of studies
revealed a considerable clinical heterogeneity even within
LADA itself, often reflecting underlying immunological
diversity (e.g. presence of single or multiple antibodies,
variability in GADAb titers). Lohmann and coworkers
reported that diabetic patients with elevated GADAb
titers, or presence of multiple antibodies to beta-cells
(defined as “LADA–1 patients”), have lower mean BMI
values and a lower prevalence of long–term complications
compared with patients with a single antibody positivity
and/or low titers of circulating antibodies (defined as
“LADA–2 patients”) [7]. In line with these findings, we
recently reported, in a LADA cohort from Sardinia, a
lower mean value and larger variability of BMI in com-
parison with T2D patients of the same ethnic origin, and
we provided evidence that a BMI value below 28 kg/m2
is a strong predictor of progression towards insulin-
dependence within 4 years [8]. This finding raises the
general question as to whether a particular distribution
of body fat in this form of diabetes can influence the clin-
ical outcome. Only relatively few investigations have de-
scribed the distribution of BMI in LADA [4-8] and no
systematic studies were focused so far on body compos-
ition (BC) in this form of diabetes, using appropriate and
validated instrumental procedures such as Dual energy X-
ray absorptiometry (DXA) [9]. Moreover, since central
obesity is a well recognized risk factor for cardiovascular
(CV) disease, the assessment of the relative amount of fat
and its distribution into the body compartments might help
the physician identify sub–groups of patients with increased
CV risk, thereby improving the prevention of long–term
complications in this form of diabetes. The aim of the
present study was to determine the BC, in a previously re-
cruited cohort of LADA patients from Sardinia, by using
DXA scan which is currently considered the clinical gold
standard for BC assessment, and to evaluate the fat and
lean mass distribution in comparison with two control
groups, i.e. antibody-negative T2D patients and adult-
onset (> age 30) T1D patients. Finally, we evaluated the
impact of BC on the progression towards beta-cell failure.
Methods
The characteristics of LADA patients have been described
in our previous study [8]. Of the original cohort of 251 pa-
tients, 210 (118 women and 92 men, median age 54 years,range 35-65 years) agreed to undergo a full BC assessment
and their clinical characteristics were representative of the
original cohort. All LADA patients did not receive insulin
therapy over the next 6 months after diagnosis. The
duration of diabetes lasted from no less than 8 months to
no more than 5 years, and none of these patients at onset
presented with ketoacidosis and/or significant weight loss.
Two control groups were also recruited: (i) 210 age – and
gender–matched T2D patients who were demonstrably
GADAb–negative; (ii) 30 T1D patients whose diabetes
had developed after the age of 30 but had displayed ketoa-
cidosis and/or had received insulin treatment in the
6 month after diagnosis. In this group of patients the
sudden onset and the immediate requirement of insulin
replacement therapy were considered sufficient to warrant
the diagnosis of T1D, therefore GADAb antibodies were
not determined.
All study participants were of Sardinian origin for at
least two generations and none of them showed signs of
severe liver or kidney disease. The study was approved
by the local Ethics Committee (University of Sassari,
Sardinia, Italy), and all participants provided a signed
informed consent to participate in the study.
In all study participants body height (m) was measured
using a stadiometer and body weight with an electronic
balance with accuracy up to 0.1 kg. BMI was calculated
as weight/height2 (kg/m2). Waist circumference (cm) was
measured at the iliac crests in the upright position.
Whole-body and segmental DXA scans were carried
out in all study participants to assess percent fat mass
(FM) and lean body mass (LBM) by using a QDR 4500 W–
Explorer (Hologic Inc, Bedford, MA). Densitometric data
analysis was performed by the software “Subregion Whole
Body” which generates values in kilograms and percent of
FMs and LBM for the whole body as well as for distinct
body segments (upper limbs, trunk, lower limbs). The
instrument radiation exposure during an examination of
DXA was relatively low (1 mSv/d, micro-Sievert) according
to the manufacturer.
During the insulin-free period LADA patients were
treated with nutritional therapy, although in 58/210
patients (28%) oral hypoglycemic agents (OHA) were also
added in order to improve the metabolic control. Insulin
treatment was considered whenever patients displayed
one of the following conditions: (i) early appearance of
ketosis; (ii) significant body weight loss in spite of the
usual diet; (iii) postprandial glucose level above 180mg/dl
despite maximum allowed dose of OHA.
Statistical analysis was performed using SPSS statistical
software (version 16; SPSS, Chicago, IL). The values of
anthropometric and DXA variables were expressed as
means ± standard deviations. Differences between categor-
ical variables were analysed by the Pearson χ2 test, whereas
differences between scalar variables were tested using
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ANOVA when more than two groups were compared.
All comparisons were adjusted for age at recruitment
and duration of disease. P-values ≤0.01 were considered
statistically significant.
Results
The clinical characteristics of all study participants are
displayed in Table 1. Average BMI and waist circumfer-
ence were significantly lower in LADA patients than in
antibody-negative T2D (p < 0.0001) whereas they were
significantly higher when compared to adult-onset T1D
(p = 0.0002). The frequency of metabolic syndrome in
the LADA group was 88/210 (42%), that is, intermediate
between that of GADAb–negative T2D (87%) and adult-
onset T1D (10%) and the differences between LADA
and the other control groups were statistically significant
(p < 0.001, chi–square).
Whole body DXA
Mean values of body DXA parameters in the three groups
of diabetes patients stratified by gender are reported in
Table 2. In LADA patients the percent FM was similar to
that of T1D and significantly lower compared to
GADAb–negative T2D patients (P < 0.0001 in both gen-
ders). Percent LBM showed a similar trend, i.e. values in
LADA patients were comparable to those of patients with
adult-onset T1D and significantly higher than in GADAb-
negative T2D patients (p = 0.0001). As expected, women
showed on average 40-50% higher level of FM compared
to men in all groups of patients.
Segmental DXA
Segmental DXA results are shown in Table 3. Among
men, percent FM was significantly lower (p < 0.0001) in
LADA than in T2D patients in all body segments (upper
limbs, trunk and lower limbs), whereas no difference
was detected between male LADA and adult-onset T1D
patients. Among women, percent FM was significantly
higher in LADA compared to antibody-negative T2D
patients, but limited to the upper and lower segments,
whereas in the truncal segment it was significantly lower
(p < 0.0001). Compared to T1D women, LADA womenTable 1 Clinical characteristics of study participants
Variables LADA GADAb
Number of patients 210
M:F 92:118
Age at onset (years) 55.1 ± 10.6 5
Body mass index at onset (kg/m2) 28.1 ± 5.3
Waist circumference at onset (cm) 95.2 ± 10.0 1
Metabolic syndrome (%) 88 (42%) 1
§LADA vs T2D; #LADA vs adult–onset T1D.displayed a significantly increased FM in the truncal seg-
ment, whereas no significant difference was found in the
upper and lower compartments. Segmental LBM showed
similar patterns in all groups but in reverse order.
Progression of LADA patients towards insulin
dependence according to BMI and BC parameters
The influence of BMI and BC parameters on the progres-
sion of diabetes was investigated by subdividing LADA
patients into subgroups according to the median values of
BMI, whole body FM and truncal FM. The proportion of
LADA patients who became insulin-dependent after
4 years of follow up was 55% among those with a BMI
below the median value (26 kg/m²) and only 30% among
those with a BMI above this cut-off (p = 0.0001). The pro-
portion of LADA patients with insulin dependence within
4 years was higher in patients with truncal fat below
the median value (57% vs. 37%, p = 0.004), whereas no
difference was observed when subgroups were defined
according to the median value of the whole–body percent
FM (52% vs. 43%, n.s.).
Discussion
Latent autoimmune diabetes in adults accounts for roughly
10% of all cases of diabetes. The largest LADA cohorts
analyzed so far [4-7] revealed a significant degree of het-
erogeneity of this form at the immunological level, whereas
the existence of clinical heterogeneity is relatively less
documented, especially for anthropometric and BC param-
eters. In this study we have analyzed the distribution of
BMI and BC in a large cohort of LADA patients from the
genetically homogeneous population of Sardinia [8], and
compared the results with GADAb-negative T2D patients
and T1D patients with onset after age 30.
Our data shows that the average BMI in the whole
cohort of LADA patients is nearly 10% lower than in
antibody-negative T2D patients and it displays a larger
variability than in adult-onset T1D. This finding was
further confirmed by BC analysis through DXA scans,
which revealed that LADA patients as a whole have signifi-
cantly less fat deposits than classical non-autoimmune T2D
patients, substantially comparable to that of adult–onset
T1D, with gender differences reflecting the physiological-negative T2D Adult-onset T1D P-value
210 30
92:118 11:19 n.s.§; n.s.#
7.7 ± 10.1 46.6 ± 7.9 n.s.§; <0.0001#
30.8 ± 6.1 25.0 ± 3.5 <0.0001§; 0.0002#
01.1 ± 12.1 86.3 ± 10.6 <0.0001§; 0.0002#
82 (87%) 3 (10%) <0.0001§; 0.0008#
Table 2 Whole body composition in LADA, T2D and adult-onset T1D patients
Variables Gender LADA GADab-negative T2D Adult-onset T1D p-value
Fat mass (%) M 21.6 ± 4.7 27.2 ± 5.9 21.3 ± 4.9 <0.0001§ ; n.s.#
F 33.8 ± 5.5 37.1 ± 6.1 30.3 ± 6.8 0.0001§; n.s.#
Lean body mass (%) M 75.2 ± 4.5 70.4 ± 6.5 75.6 ± 4.8 <0.0001§; n.s. #
F 63.5 ± 5.3 59.7 ± 6.9 66.8 ± 6.6 <0.0001§; n.s.#
§LADA vs T2D; #LADA vs adult–onset T1D.
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also revealed in LADA patients the existence of a peculiar
distribution of fat into the body compartments, depending
on gender. Among men, adipose tissue is significantly lower
in LADA than in T2D patients with no appreciable differ-
ences across the three body segments. In contrast, in
LADA women adipose tissue surpasses the proportion
found in T2D in upper and lower body segments, whereas
it is relatively reduced in the truncal segment. Thus, fat
deposits in LADA women accumulate mostly in peripheral
body segments, as observed in T1D women, although a
subgroup of LADA women displays a truncal fat accumula-
tion resembling that of T2D. A similar pattern in LBM
distribution across the body compartments is observed as
well, in parallel with the variations in FM. Taken together,
these data indicate that in LADA women fat deposits
tend to follow a more peripheral pattern that in classic,
non-autoimmune T2D, whereas in men they follow a
T1D-like pattern.
As for the relationship between fat deposits and disease
progression, we found that a lower truncal fat percentage
is a significant predictor of beta-cell exhaustion, which is
consistent with our previous finding that LADA patients
with low BMI values will develop a need for insulin treat-
ment sooner than patients with higher BMI values [8]. We
also confirm that the frequency of metabolic syndrome inTable 3 Segmental body composition in LADA patients and c
Variables Gender LADA GADa
Upper limbs FM (%) M 21.5 ± 5.3
F 40.9 ± 6.9
Upper limbs LBM (%) M 73.9 ± 5.3
F 55.3 ± 6.8
Trunk FM (%) M 21.0 ± 6.0
F 30.8 ± 8.0
Trunk LBM(%) M 78.0 ± 6.0
F 68.5 ± 8.0
Lower limbs FM (%) M 22.0 ± 4.4
F 38.9 ± 5.3
Lower limbs LBM (%) M 73.8 ± 4.3
F 57.9 ± 5.2
§LADA vs T1D; #LADA vs T2D.LADA as a whole is significantly reduced compared to
T2D, although higher than in adult-onset T1D patients.
The specific mechanisms accounting for the existence of
distinct BC patterns in LADA subgroups are not known,
and we can only speculate that they may be related to the
severity of the underlying autoimmune process, which
entails a variable duration of the residual beta cell func-
tion. As for the risk of late complications, it is known that
excess abdominal fat increases the CV risk, whereas
accumulation of fat in lower-body subcutaneous areas
may be protective, as recently suggested by Lim et al. [10].
Since in T2D, especially women, adipose tissue deposits
are larger in the truncal and upper segments and smaller
in the lower body regions [11] this may explain, at least in
part, why they show an increased risk of premature CV
disease. On the same basis, we postulate that LADA
women, showing specifically a peripheral fat accumulation
may be more protected against CV risk compared with
LADA women whose fat distribution is closer to that of
T2D women. To what extent such patterns, if any, can
influence the susceptibility to late complication is at
present unknown, and deserves to be tested in cohorts
with more extended follow–ups.
The present study has several strengths. First, the
LADA study cohort belongs to a genetically homoge-
neous ethnic group, thus minimising the influence of aontrol groups
b-negative T2D Adult-onset T1D p-value
29.7 ± 10.6 21.6 ± 5.8 <0.0001§ ; n.s.
31.2 ± 10.4 37.3 ± 11.8 <0.0001§ ; n.s.
66.4 ± 10.5 74.0 ± 5.6 <0.0001§ ; n.s.
64.9 ± 10.3 58.7 ± 11.3 <0.0001§ ; n.s.
24.5 ± 6.5 20.0 ± 6.4 0.0002§ ; n.s.
38.1 ± 7.8 25.5 ± 6.8 <0.0001§ ; 0.005#.
74.8 ± 6.5 79.2 ± 6.4 0.0006§; n.s.
58.0 ± 7.8 73.8 ± 6.7 <0.0001§ ; 0.004#.
27.0 ± 4.0 23.2 ± 4.8 <0.0001§; n.s.
28.5 ± 8.3 38.7 ± 9.2 <0.0001§ ; n.s.
69.5 ± 4.0 73.0 ± 4.8 <0.0001§; n.s.
67.6 ± 8.4 58.3 ± 9.0 <0.0001§; n.s.
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DXA which is considered the gold standard for assessing
visceral and subcutaneous fat deposits, and it gives more
accurate information than the simpler anthropometric
measurements adopted in earlier studies. However, our
findings are essentially descriptive and, at the moment, a
consistent explanation of the BC heterogeneity found in
LADA is not available, and the short follow–up period
does not allow to test the impact of BC on the long-term
outcome of the disease.
Conclusions
In a cohort of LADA patients, we observed a BC different
from that of non–autoimmune T2D, the former being
much closer to adult–onset T1D, as pointed out by previ-
ous studies. The relative depletion of visceral fat observed
in LADA patients is associated with a faster progression
towards insulin dependence. We suggest that the LADA
patients with larger fat mass in the peripheral regions
may be exposed to a lower risk of late cardiovascular
complications than in T2D, a hypothesis that deserves
further testing in larger clinical trials.
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